Skip to main content

Oncology Institute (US:TOI) — Company Overview, News & Financial Data

Oncology Institute logo
TOIOncology Institute
Oncology Institute primary media
Company profile

Oncology Institute

Oncology Institute (NASDAQ:TOI) focuses on delivering comprehensive cancer care through an integrated network. The company aims to provide patients with personalized treatment plans, leveraging cutting-edge research and technology to improve outcomes. Oncology Institute's projects span across various aspects of cancer treatment, including innovative therapy development, community-based clinical trials, and advancing precision medicine. The objective is to make high-quality oncology care accessible and affordable, ensuring a supportive environment for patients and their families. By continuously expanding its services and facilities, Oncology Institute strives to meet the growing needs of the communities it serves, promising a future where cancer treatment is more effective and compassionate.

Snapshot

Public USOwnership
2007Year founded
800Employees
Cerritos, United StatesHead office
Loading Map...
Global footprint

Operations

All Locations
United States

Products and/or services of Oncology Institute

  • Comprehensive cancer care services, offering personalized treatment plans including chemotherapy, radiation therapy, and surgical options.
  • Cancer research programs, focusing on developing innovative treatments and understanding cancer biology.
  • Supportive care services, providing emotional, nutritional, and rehabilitation support for patients and their families.
  • Educational resources and events, aimed at increasing awareness about cancer prevention, early detection, and treatment options.
  • Advanced diagnostic services, using cutting-edge technology for accurate cancer diagnosis and staging.
  • Collaboration with pharmaceutical companies to develop and test new cancer drugs, enhancing treatment options available to patients.

Oncology Institute executive team

  • Dr. Daniel Virnich FACHE, M.B.A., M.D.CEO & Executive Director
  • Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H.Chief Medical Officer
  • Mr. Robert CarterChief Financial Officer
  • Mr. Austin LeeVP of Accounting & Controller
  • Mr. Rakesh PandaChief Information Officer
  • Ms. Kristin EnglandChief Administrative Officer
  • Mr. Mark Hueppelsheuser Esq.General Counsel
  • Mr. Nolan MarianoChief People Officer
  • Mr. Jordan McInerneyChief Development Officer
  • Mr. Stephen CellaSenior Vice President of Finance